David, Ebenezer Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes. [electronic resource] - Blood Dec 2010 - 5285-8 p. digital Publication Type: Journal Article; Research Support, Non-U.S. Gov't ISSN: 1528-0020 Standard No.: 10.1182/blood-2010-03-272393 doi Subjects--Topical Terms: Apoptosis--drug effectsAutophagyBoronic Acids--pharmacologyBortezomibCell Line, TumorDrug SynergismDrug Therapy, CombinationHumansMultiple Myeloma--drug therapyProteasome InhibitorsPyrazines--pharmacologyQuinolonesUbiquitination--drug effects